Morgan Stanley Call 500 TYL 21.03.../ DE000MG0XTF8 /
7/16/2024 8:48:40 PM | Chg.+0.010 | Bid10:00:34 PM | Ask10:00:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.730EUR | +1.39% | - Bid Size: - |
- Ask Size: - |
Tyler Technologies C... | 500.00 USD | 3/21/2025 | Call |
GlobeNewswire
6/27
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
6/26
Basis Technologies Improves Planning Capabilities for Advertisers Through AI-Powered Media Automatio...
GlobeNewswire
6/18
Kite Realty Group Trust to Report Second Quarter 2024 Financial Results on July 30, 2024
Newsfile Corp
6/18
UneeQ Transforms Enterprise AI by Allowing Organizations to Leverage Their AI Investments and Create...
GlobeNewswire
6/17
nCino Deploying Banking Advisor, a Generative AI Solution to Drive New Efficiencies in Financial Ins...
GlobeNewswire
6/14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
6/13
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BE...
GlobeNewswire
6/13
Infinidat Wins Multiple Awards from Storage Magazine, UK at the 2024 Storries XXI
GlobeNewswire
6/12
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over...
GlobeNewswire
6/10
Silvaco to Announce First Quarter 2024 Financial Results and Provide Second Quarter and Full Year 20...
GlobeNewswire
6/7
AMERICAN SALARS FILES NI 43-101 TECHNICAL REPORT ON BLACKROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
6/5
Cipher Mining Announces Significant Upgrades to its Mining Fleet and Increases Target Hash Rate and ...
GlobeNewswire
6/5
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibito...
GlobeNewswire
6/5
ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psori...